Medtronic (MDT) said Tuesday it appointed Chad Spooner as chief financial officer of new diabetes firm MiniMed, ahead of its planned separation into a standalone public company.
The company said that effective July 14, Spooner will have oversight of the finance function for Medtronic Diabetes as it readies to be fully independent.
Spooner most recently served as CFO of global consumer goods firm BIC, Medtronic said.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.